Kerr, Tannock on the ' Triangle of Mediocrity ' Holding Oncology Back Kerr, Tannock on the ' Triangle of Mediocrity ' Holding Oncology Back

With nearly 75 years of oncology experience between them, Drs Kerr and Tannock take aim at the pitfalls of precision medicine and the ' triangle of mediocrity ' among academic medicine, pharma companies, and the FDA.Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news